Expanded Access to Venetoclax

Overview

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Venetoclax prior to approval by the local regulatory agency. Availability will depend on territory eligibility. Participating sites will be added as they apply for and are approved for the EAP. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

SparkCures ID 924
Trial Phase Expanded Access
Enrollment Information Not Available
Treatments
Trial Sponsors
  • AbbVie
NCT Identifier

NCT03123029

Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

The following criteria is provided for health care professionals.

  • The participant must not be eligible for a venetoclax clinical trial.
  • Pediatric participants may be evaluated on a case by case basis.

US Trial Locations

Please visit the ClinicalTrials.gov page for historical site information.

View Centers

Resources

There are no resources, links or videos to display for this clinical trial.